However, recent studies have cast doubt on whether the low-flow state truly portends a poorer prognosis. 8 Studies also appear conflicted on the impact of surgery on these patients. 9, 10 Furthermore, reduced LVEF to <50% is an ACC/AHA class I indication for aortic valve replacement (AVR), even in the absence of symptoms. 11, 12 To date, no study has yet examined the deterioration of LVEF over time in patients with low-flow compared to normal-flow severe AS. Thus, we aimed to examine retrospective paired echocardiographic studies to (1) identify factors associated with LVEF deterioration to <50% and (2) compare clinical outcomes of low-flow vs normal-flow severe AS with preserved LVEF in our Asian population.
| METHODS
We examined consecutive patients from the years 2000-2010 retrospectively who had paired echocardiography for medically treated severe aortic stenosis (AS). There were 886 subjects with severe AS (Figure 1 ). However, only 128 subjects had paired echocardiography and initial preserved LVEF (>50%) on medical therapy. For patients with more than two echocardiographic studies carried out in the study period, we considered the first and last studies. We compared 56 pa- and PWTs is end-systolic posterolateral wall thickness.
All echocardiographic parameters were measured in accordance with guidelines and standards of the American Society F I G U R E 1 Study population of patients with severe aortic stenosis and paired echocardiographic studies of Echocardiography/European Association of Cardiovascular Imaging. 13, 14 The subjects were divided into Group A-subjects with significant LVEF deterioration (to below 50%); and Group B-subjects with LVEF remaining at or above 50% on subsequent echocardiography ( Figure 1 ). 
| RESULTS

| Factors associated with LVEF deterioration in low-flow severe AS
Of the 128 patients studied, 44% (n=56) were patients with low-flow severe AS. Of these, 10 (18%) experienced significant LVEF deterioration to <50% on the subsequent echocardiography (Group A), while 46 (82%) had preserved LVEF (Group B). Factors associated with this outcome were identified by univariate and multivariate analyses (Table 1) . Hypertension remained an independent factor associated with LVEF deterioration. Time intervals between echocardiographic studies were not associated with the outcome.
Of the echocardiographic parameters studied, a higher end-systolic stress remained a significant independent factor associated with LVEF deterioration on multivariate analysis. The presence of hypertension had a 90% sensitivity, 73% specificity, 63% positive predictive value, and 94% negative predictive value in association with a subsequent deterioration of LVEF to <50%. By comparison, an end-systolic wall stress of >84×10 3 dyn/cm 2 had a 70% specificity, 89% sensitivity, 76%
positive predictive value, and 86% negative predictive value in an association with a subsequent deterioration of LVEF to <50%.
| Factors associated with LVEF deterioration in normal-flow severe AS
By comparison, 72 patients (56%) had normal-flow severe AS. Similar to low-flow, 18% (n=13) of these patients experienced significant LVEF deterioration to <50% on subsequent echocardiography (Group A). Factors associated with this outcome were tabulated ( Table 2 ).
Hypertension remained an independent factor associated with the outcome, while other baseline demographic and clinical comorbidities were similar in Group A and Group B. The time intervals between echocardiographic studies were not associated with the outcome. specificity, 61% positive predictive value, and 89% negative predictive value in association with subsequent deterioration of LVEF to <50%. By comparison, end-systolic wall stress at optimized cutoff of >70×10 3 dyn/cm 2 had a 92% sensitivity, 62% specificity, 55% positive predictive value, and 94% negative predictive value in association with subsequent LVEF deterioration to <50%.
| Echocardiographic parameters on subsequent echocardiography
We examined our study population in terms of echocardiographic parameters on subsequent echocardiography. In the patients with lowflow severe AS, Group A had a higher end-diastolic volume index and end-systolic wall stress compared to Group B, but a lower septal S′ velocity, RWT, and systemic arterial compliance on univariate analysis (Table 3) . By comparison, in the normal-flow AS, end-diastolic volume index, left ventricular mass index, and end-systolic wall stress were higher in Group A (compared to Group B), although with lower systemic arterial compliance and transmitral deceleration time.
| Clinical outcomes
The patients that experienced significant LVEF deterioration (Group A) showed a trend of higher rates of cardiovascular mortality (45% vs 32%, P=.162). Morbidity in terms of admission for congestive cardiac failure (37% vs 31%, P=.438) was not significantly higher in Group A ( Figure 2 ). However, Kaplan-Meier curve demonstrates that these patients experienced composite major adverse cardiovascular events .154
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Septal A′ velocity (ms) (Continues) (defined as cardiovascular mortality or admission for congestive cardiac failure) earlier and more frequently (log-rank 13.673, P<.001; Figure 3 ).
In comparing the clinical outcomes of low-flow vs normal-flow severe AS, we found no significant difference in cardiovascular mortality (34% vs 33%, P=.374), or in cardiovascular morbidity in terms of admission for congestive cardiac failure (35% vs 36%, P=.806; Table 4 ). The Kaplan-Meier curve comparing low-flow to normal-flow AS in terms of major adverse cardiovascular event did not demonstrate any significant difference in outcome (log-rank 0.048, P=.827; Figure 4 ). However, AVR rates were significantly lower in the lowflow AS population (18% vs 43%, P=.005). Of the 41 patients who underwent AVR, 10 had low-flow severe AS, while 31 had normal-flow.
Twelve patients subsequently had admissions for congestive cardiac failure (29%, compared to 33% in those without AVR), and mortality was 22% after AVR (n=9, compared to 35% in those without AVR).
Patients without AVR were followed up for a mean of 5±3 years, while patients with AVR were followed up for a mean of 3±2 years (Table 4) .
| DISCUSSION
| Comparing deterioration of ejection fraction in low-flow vs normal-flow severe AS
We identified clinical and echocardiographic factors associated with LVEF deterioration in patients with low-flow vs normal-flow severe AS. LVEF deterioration was similarly prevalent in the low-flow AS group compared to the normal-flow AS group, contrary to previous studies suggesting a more "advanced" disease of the low-flow group. 6 The independent factors associated with LVEF deterioration demonstrated were generally related to (1) increased left ventricular afterload (presence of hypertension, increased end-systolic wall stress) or (2) subclinical LV systolic dysfunction (lower septal S′ velocity), and these were comparable to published literature examining predictors of poor clinical outcomes. 15 However, to our knowledge, this was the first time paired echocardiography has been employed to compare factors associated with LVEF deterioration to <50% in low-flow vs normal-flow severe AS.
Exploring the pathophysiology of severe AS helped shed light on the important factors associated with LVEF deterioration. Pressure overload (eg, hypertension and AS) may result in left ventricular hypertrophy and dilatation, 16, 17 resulting in eventual heart failure. 18, 19 Increased end-systolic has further been consistently a poor prognostic marker of left ventricular remodeling and afterload. .
(Continues)
The other factors identified were related to relative reduction in LV systolic function. Mitral annular tissue Doppler S′ velocity has been shown to be reliably related to the degree of systolic dysfunction. [25] [26] [27] [28] We found poorer LVEF outcomes in both the low-flow and normalflow populations with lower septal S′ velocity. 
| Comparing clinical outcomes in low-flow vs normal-flow severe AS
Of note, we found that the patients with low-flow AS were significantly older than their normal-flow counterparts, which was consistent with previous studies. 8 However, the clinical outcomes of patients comparing low-flow to normal-flow were strikingly similar in our cohort. This may cast further doubt as to whether low-flow severe AS with paradoxically preserved LVEF is a distinct clinical entity with worse prognosis. [3] [4] [5] [6] Our cohort differed from cohorts of previous studies, being an Asian population, with a higher percentage of patients in the lowflow category. In fact, our study found that a significant proportion of patients with severe AS were low-flow (44% of patients with SVI <35 mL/m 2 ). 6, 8 The relative frequency of low-flow AS with preserved LV ejection fraction may perhaps be attributed to ethnic and genetic differences between populations. SVI was found to be generally lower in Asians compared to Europeans. 29, 30 A previous study in a Japanese population had also demonstrated that low-flow severe AS was more similar in prognosis to moderate AS than severe AS. 8 Nevertheless, in severe AS, the mortality without AVR remains high. Despite this knowledge, the AVR rates in our population were low. This may be related to patient preference for conservative management despite fulfilling criteria for surgical valve replacement, or significant medical comorbidities which preclude surgical treatment.
It is also due to patient selection, as our subjects were all medically managed, and patients who had AVR in between their first and second echocardiography were excluded from our study. Nevertheless, the low rates of AVR may in part have contributed to the higher mortality and morbidity in our population. 11, 12 Valve replacement rates were particularly low in the low-flow population. 6 This may have been due to the perception that low-flow AS was less severe or that the prognostic implications of surgery were unclear in this subgroup. Furthermore, caution must be taken that conventional parameters of AS severity in previous study (eg, valvuloarterial impedance, aortic valve resistance, stroke work loss, systemic arterial compliance) may not be reliable in low-flow. [31] [32] [33] While otherwise useful, these conventional parameters may underestimate severity in low-flow AS as the effect of afterload appears more significant in the low-flow state. 6 Furthermore, the dilated left ventricles seen in patients with low-flow AS compared to normalflow AS may also cause the parameters to be deranged. Indeed, despite having more deranged prognostic indices as mentioned above,
we found no significant differences in clinical outcomes between the low-flow and normal-flow AS groups over the subsequent follow-up period.
Therefore, we postulate that managing the increased afterload 
| Limitations
This study was moderately sized and based on paired echocardiographic studies. We also did not assess symptoms of angina, syncope, and dyspnoea or biomarkers such as NT-pro-brain natriuretic peptides as these were not the foci of our study. The differential effects of various components of medical management such as the use of renin-angiotensin blockers were also not quantified. Furthermore, the role of surgery was not adequately explored. In fact, our cohort had low rates of AVR. Although our center offered transcatheter aortic valve implantation (TAVI) in addition to AVR as therapeutic options for severe AS, part of the study was in the pre-TAVI era.
Our cohort consisted of medically treated subjects including those who declined intervention despite fulfilling criteria for AVR and those with significant comorbidities. This may also in part explain the lower rates of AVR in the group with reduced LVEF, as the patients who underwent AVR after the first echocardiography but before the second had been excluded. In addition, the low AVR rate may indeed contribute to the high cardiovascular mortality on follow-up. Treatment was also not randomized, which limited our ability to understand how the groups were differently managed to result in differences in clinical outcomes.
Furthermore, given the retrospective nature of this study using paired echocardiographic studies to assess LVEF deterioration, it may have resulted in selection bias as we excluded patients with severe AS with only one echocardiographic study or those who underwent AVR before the second echocardiography. This may represent a significant group of patients lost to follow-up or had aortic valve surgery or sustained adverse events which were not captured in our study. Our cohort may be of lower risk with lower event rates, and the patients in our cohort have a different natural history. In addition, even if the subjects in this study have the same natural history of AS, we studied them at different points, leading to lead time and length time biases. While these may be randomly distributed, they might still account for some of the results reported and remained an inherent limitation of the study design. However, this was the first study analyzing paired echocardiography of medically treated subjects and comparing low-flow to normal-flow severe AS.
| CONCLUSIONS
Severe AS was associated with high cardiovascular mortality and morbidity. We found a relatively high frequency of low-flow severe AS in 
